Efficacy of autologous expanded bone marrow derived mesenchymal stem cells (axBM-MSC) in the treatment of patients with chron's disease who have failed to standard therapy: an open-label, randomized controlled clinical trial phase II

Saved in:
Bibliographic Details
Published inCytotherapy (Oxford, England) Vol. 19; no. 5; p. e23
Main Authors Arturo, Jhann, Lucena, Carolina, Perez, Carlos, Esteban, Clara, Sandoval, Angie L. Vivas, Bastidas, Yazmin, Ruiz, Carlos, Guerrero, Octavio Segura, Segura, Octavio, Lucena, Elkin
Format Journal Article
LanguageEnglish
Published 01.05.2017
Subjects
Advanced Basic Science
Other
Online AccessGet full text

Cover

More Information
ISSN:1465-3249
DOI:10.1016/j.jcyt.2017.03.059